Today: Dec 21, 2024
RU / EN
Last update: Oct 30, 2024
Macular Pigment Optical Density Alteration as an Indicator of Diabetic Macular Edema Development

Macular Pigment Optical Density Alteration as an Indicator of Diabetic Macular Edema Development

Bikbov M.M., Zainullin R.M., Faizrakhmanov R.R.
Key words: diabetic macular edema; macular pigment; macular pigment optical density.
2015, volume 7, issue 3, page 73.

Full text

html pdf
2798
2104

The aim of the investigation was to reveal the peculiarities of macular pigment optical density (MPOD) alteration in diabetic macular edema.

Materials and Methods. A total of 52 patients aged 55 to 71 years (mean, 63.0±5.2 years) were studied. The patients suffering from diabetes mellitus type 2 with diabetic macular edema (28 subjects, 30 eyes) were included in group 1 (main group). Group 2 (control group) included 24 patients (35 eyes) who did not suffer from any ophthalmic diseases and diabetes. All subjects underwent standard ophthalmic examination and fundus photographing followed with MPOD measurement using reflectometry method with non-mydreatic fundus camera VISUCAM 500® (Carl Zeiss Meditec AG, Germany).

Results. 78% of 28 patients from group 1 showed decline in all MPOD measurements as compared to control group. In particular, their mean MPOD was estimated as 0.10±0.01 standard units of optical density (р<0.05), while in the control group the same index was 0.25±0.01 standard units of optical density (р<0.05). The most significant MPOD reduction was observed in the projection of the retina edema area.

Conclusion. In diabetic macular edema, sharp decline in MPOD indices occurs. The correlation between quantitative MPOD indices and the size of the edema area has been revealed.

  1. Chucair A.J., Rotstein N.P., SanGiovanni J.P., During A., Chew E.Y., Politi L.E. Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007; 48(11): 5168–5177, http://dx.doi.org/10.1167/iovs.07-0037.
  2. Raman R., Rajan R., Biswas S., Vaitheeswaran K., Sharma T. Macular pigment optical density in a South Indian population. Invest Ophthalmol Vis Sci 2011; 52(11): 7910–7916, http://dx.doi.org/10.1167/iovs.11-7636.
  3. Kaya S., Weigert G., Pemp B., Sacu S., Werkmeister R.M., Dragostinoff N., Garhöfer G., Schmidt-Erfurth U., Schmetterer L. Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects — a study using spectral fundus reflectance. Acta Ophthalmol 2012; 90(5): e399–e403, http://dx.doi.org/10.1111/j.1755-3768.2012.02423.x.
  4. Rothenbuehler S.P., Wolf-Schnurrbusch U.E.K., Wolf  S. Macular pigment density at the site of altered fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol 2011; 249(4): 499–504, http://dx.doi.org/10.1007/s00417-010-1528-1.
  5. Iannaccone A., Mura M., Gallaher K.T., Johnson E.J., Todd W.A., Kenyon E., Harris T.L., Satterfield S., Johnson K.C., Kritchevsky S.B. Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sample. Invest Ophthalmol Vis Sci 2007; 48(4): 1458–1465, http://dx.doi.org/10.1167/iovs.06-0438.
  6. Астахов Ю.С., Шадричев Ф.Е., Красавина М.И., Гри­горьева Н.Н. Современные подходы к лечению диабетического макулярного отека. Офтальмологические ведомости 2009; 2(4): 59–69. Astakhov Y.S., Shadrichev F.E., Krasavina M.G., Grigorieva N.N. Modern approaches to diabetic macular edema treatment. Oftal’mologicheskie vedomosti 2009; 2(4): 59–69.
Bikbov M.M., Zainullin R.M., Faizrakhmanov R.R. Macular Pigment Optical Density Alteration as an Indicator of Diabetic Macular Edema Development. Sovremennye tehnologii v medicine 2015; 7(3): 73, https://doi.org/10.17691/stm2015.7.3.10


Journal in Databases

pubmed_logo.jpg

web_of_science.jpg

scopus.jpg

crossref.jpg

ebsco.jpg

embase.jpg

ulrich.jpg

cyberleninka.jpg

e-library.jpg

lan.jpg

ajd.jpg

SCImago Journal & Country Rank